COMP <GO>
PEN vs SOLV // FORWARD P/E MULTIPLE
Penumbra Inc. (NYSE) VS. Solventum Corporation (NYSE) • 15-METRIC TALLY: PEN 6
— SOLV 7
▲ FORWARD P/E MULTIPLE LEADER: SOLV
LAST: $318.95 (-0.94%) • MKT CAP: $12.68B
forward-pe
60.0x
LAST: $81.33 (-2.67%) • MKT CAP: $14.22B
forward-pe
8.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PEN VS. SOLV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PEN | SOLV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.10% | 53.50% | +13.60 | PEN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.60% | 18.70% | -8.10 | SOLV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 52.0x | 7.3x | +44.70 | SOLV | /valuation <GO> |
| Free Cash Flow Yield | 1.38% | -0.07% | +1.45 | PEN | /fcf-yield <GO> |
| Operating Margin | 13.50% | 26.20% | -12.70 | SOLV | /operating-margins <GO> |
| Net Profit Margin | 12.70% | 18.70% | -6.00 | SOLV | /net-margins <GO> |
| Revenue Growth (YoY) | 17.50% | 0.90% | +16.60 | PEN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 21.05 | 2.25 | +18.80 | PEN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | PEN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.9 | 43.4 | +8.50 | PEN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 1.06 | -0.15 | SOLV | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 60.0x | 8.5x | +51.50 | SOLV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.68B | $14.22B | -$1.54B | SOLV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PEN REV | SOLV REV | PEN GROSS % | SOLV GROSS % | PEN FCF | SOLV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.40B | $8.32B | 67.1% | 53.5% | $174.9M | -$10.0M |
| FY 2024 | $1.19B | $8.25B | 63.2% | 55.6% | $147.3M | $805.0M |
| FY 2023 | $1.06B | $8.20B | — | — | $49.7M | $1.55B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PEN // BETA 0.91
SOLV // BETA 1.06